Hematogenix
Aybuke Cabilar has a strong background in the biomedical and medical microbiology fields, currently serving as a Study Coordinator at Hematogenix since July 2022. Prior to this role, Aybuke worked as a Laboratory Technician at Prenetics EMEA from January 2021 to May 2022. Educational qualifications include a Master of Science in Medical Microbiology from The University of Manchester (2018-2019) and a Bachelor of Science in Biomedical Sciences from the University of Hull (2015-2018).
This person is not in the org chart
This person is not in any offices
Hematogenix
1 followers
Hematogenix, a global cancer-focused life science company serving the pharmaceutical & biotechnology industry as well as community physicians. With passionate scientists and board-certified clinical and anatomic pathologists and hematopathologists from around the world, Hematogenix offers an array of biomarker development and testing services navigating the complexities of human diseases and clinical trials. Our global team of scientists provides reference laboratory services at our facilities around the globe: in the US, Europe, China, and Asia-Pacific. We are uniquely equipped to help clients accelerate cancer research and drug development efforts at these globally connected facilities. Hematogenix provides a complete menu of services such as Flow Cytometry, Molecular Genetics, Next Generation Sequencing (NGS), Histology / Immunohistochemistry (IHC), Cytogenetics / FISH, Pathology, Digital Pathology and Image Analysis. Our test menu reflects our commitment to utilizing the most advanced techniques to enhance patient care. We provide customized services ranging from the initial stages of research to development, and extending all the way to the implementation of targeted therapies in the clinical setting. * CAP – Accredited * CLIA – Certified * GCP – Compliant